While a few genes such as BRCA2 and HOXB13 are definitively linked to prostate cancer risk in specific patient populations [8–10], a greater proportion of prostate cancer risk may be associated with common alleles of low-to-intermediate penetrance or private alleles in families contributing to cancer risk. This evidence concerns the gene BRCA2 and prostate cancer.